SURIvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with SURI, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
SURI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | SURI ETF 2 | +1.21%– | +13.56%– | +22.83%– | +40.17%– | +43.08%– | n/a– |
| Flows | SURI ETF 2 | +$411K– | +$411K– | -$3M– | -$2M– | -$7M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | SURI ETF 2 | +20.45%– | +26.57%– | +28.64%– | n/a– |
| Max drawdown | SURI ETF 2 | -7.44%– | -12.67%– | -45.89%– | n/a– |
| Max drawdown duration | SURI ETF 2 | 9d– | 36d– | 644d– | n/a– |
Trading data
SURI | ETF 2 | |
Last sale 9/11/2026 at 1:30 PM | $19.21 | – |
| Previous close 09/10/2026 | $19.28 | – |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
SURI | ETF 2 | |
|---|---|---|
| Last price | $19.21 | – |
| 1D performance | -0.36% | – |
| AuM | $81.93 M | – |
| E/R | 2.82% | – |
Characteristics
SURI | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Simplify | – |
| Benchmark | - | – |
| N° of holdings | 24 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 7, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
SURI
USA
82.09%
Other
17.91%
ETF 2
Sectors
SURI
Healthcare
47.24%
Energy
43.36%
Other
9.4%
ETF 2
Advertisement
Diversification
SURI
Total weight of top 15 holdings out of 15
89.28%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
SURI
Plains GP Holdings LP
43.36%
Achieve Life Sciences, Inc.
11.56%
Milestone Pharmaceuticals, Inc.
4.94%
Delcath Systems, Inc.
4.07%
US0044681874
4.01%
Phathom Pharmaceuticals, Inc.
3.89%
Corcept Therapeutics, Inc.
3.15%
Celldex Therapeutics, Inc.
2.47%
Abeona Therapeutics, Inc.
2.21%
Kyverna Therapeutics, Inc.
1.89%
Inventiva SA
1.88%
Compass Pathways Plc
1.68%
LeonaBio, Inc.
1.44%
Artiva Biotherapeutics, Inc.
1.37%
Aquestive Therapeutics, Inc.
1.36%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
